Mesolimbic dopaminergic pathways in fear conditioning - PubMed (original) (raw)
Review
Mesolimbic dopaminergic pathways in fear conditioning
Marie A Pezze et al. Prog Neurobiol. 2004 Dec.
Abstract
One of the most common paradigms used to study the biological basis of emotion, as well as of learning and memory, is Pavlovian fear conditioning. In the acquisition phase of a fear conditioning experiment, an emotionally neutral conditioned stimulus (CS)--which can either be a discrete stimulus, such as a tone, or a contextual stimulus, such as a specific environment--is paired with an aversive unconditioned stimulus (US), for example a foot shock. As a result, the CS elicits conditioned fear responses when subsequently presented alone during the expression phase of the experiment. While considerable work has been done in relating specific circuits of the brain to fear conditioning, less is known about its regulation by neuromodulators; the understanding of which would be of therapeutic relevance for fear related diseases such as phobia, panic attacks, post traumatic stress disorder, obsessive compulsive disorder, or generalized anxiety disorder. Dopamine is one of the neuromodulators most potently acting on the mechanisms underlying states of fear and anxiety. Recently, a growing body of evidence has suggested that dopaminergic mechanisms are significant for different aspects of affective memory, namely its formation, expression, retrieval, and extinction. The aim of this review is to clarify the complex actions of dopamine in fear conditioning with respect to the wide-spread distribution of dopaminergic innervation over structures constituting the fear related circuitry. A particular effort is made to understand how dopamine in the amygdala, medial prefrontal cortex and nucleus accumbens--target structures of the mesolimbic dopamine system originating from the ventral tegmental area--could relate to different aspects of fear conditioning.
Similar articles
- Neurobiology of anxiety disorders and implications for treatment.
Garakani A, Mathew SJ, Charney DS. Garakani A, et al. Mt Sinai J Med. 2006 Nov;73(7):941-9. Mt Sinai J Med. 2006. PMID: 17195879 Review. - Effects of unconditioned and conditioned aversive stimuli in an intense fear conditioning paradigm on synaptic plasticity in the hippocampal CA1 area in vivo.
Li Z, Zhou Q, Li L, Mao R, Wang M, Peng W, Dong Z, Xu L, Cao J. Li Z, et al. Hippocampus. 2005;15(6):815-24. doi: 10.1002/hipo.20104. Hippocampus. 2005. PMID: 16015621 - Time-dependent involvement of the dorsal hippocampus in trace fear conditioning in mice.
Misane I, Tovote P, Meyer M, Spiess J, Ogren SO, Stiedl O. Misane I, et al. Hippocampus. 2005;15(4):418-26. doi: 10.1002/hipo.20067. Hippocampus. 2005. PMID: 15669102 - Fear extinction in rats: implications for human brain imaging and anxiety disorders.
Milad MR, Rauch SL, Pitman RK, Quirk GJ. Milad MR, et al. Biol Psychol. 2006 Jul;73(1):61-71. doi: 10.1016/j.biopsycho.2006.01.008. Epub 2006 Feb 13. Biol Psychol. 2006. PMID: 16476517 Review.
Cited by
- Reward processes in extinction learning and applications to exposure therapy.
Rosenberg BM, Barnes-Horowitz NM, Zbozinek TD, Craske MG. Rosenberg BM, et al. J Anxiety Disord. 2024 Aug;106:102911. doi: 10.1016/j.janxdis.2024.102911. Epub 2024 Jul 29. J Anxiety Disord. 2024. PMID: 39128178 Review. - Optogenetic activation of dopamine D1 receptors in island cells of medial entorhinal cortex inhibits temporal association learning.
Yokose J, Yamamoto N, Ogawa SK, Kitamura T. Yokose J, et al. Mol Brain. 2023 Nov 14;16(1):78. doi: 10.1186/s13041-023-01065-3. Mol Brain. 2023. PMID: 37964372 Free PMC article. - Evidence for the existence of facilitatory interactions between the dopamine D2 receptor and the oxytocin receptor in the amygdala of the rat. Relevance for anxiolytic actions.
Hernández-Mondragón JC, Hernández-Hernández DA, Crespo-Ramírez M, Prospero-García O, Rocha-Arrieta L, Fuxe K, Borroto-Escuela DO, Perez de la Mora M. Hernández-Mondragón JC, et al. Front Pharmacol. 2023 Oct 12;14:1251922. doi: 10.3389/fphar.2023.1251922. eCollection 2023. Front Pharmacol. 2023. PMID: 37900160 Free PMC article. - Separation of Channels Subserving Approach and Avoidance/Escape at the Level of the Basal Ganglia and Related Brainstem Structures.
Coizet V, Tannir RA, Pautrat A, Overton PG. Coizet V, et al. Curr Neuropharmacol. 2024;22(9):1473-1490. doi: 10.2174/1570159X21666230818154903. Curr Neuropharmacol. 2024. PMID: 37594168 Free PMC article. Review. - Developmental pyrethroid exposure causes a neurodevelopmental disorder phenotype in mice.
Curtis MA, Dhamsania RK, Branco RC, Guo JD, Creeden J, Neifer KL, Black CA, Winokur EJ, Andari E, Dias BG, Liu RC, Gourley SL, Miller GW, Burkett JP. Curtis MA, et al. PNAS Nexus. 2023 Apr 25;2(4):pgad085. doi: 10.1093/pnasnexus/pgad085. eCollection 2023 Apr. PNAS Nexus. 2023. PMID: 37113978 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials